US FDA issued five observations to Zydus Lifesciences after inspecting its Moraiya plant in Gujarat from Oct 5-13. Zydus will address them. The company said...
Zydus Lifesciences has received final USFDA approval for its generic Ascorbic Acid Injection, used to treat scurvy. The approval covers the drug in two strengths,...
Zydus Lifesciences jumps to Rs 1,125 on 29 June, up 2%, after extending its Sterling Biotech API acquisition deadline to 30 September 2026. Active Pharmaceutical...